Cleocin Phosphate Injection, Solution
Product Images NDC 71872-7200

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 71872-7200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7200-1.pdp (71872 7200 1)

Label for Cleocin Phosphate clindamycin injection USP, 150 mg/mL, 60 mL vial pharmacy bulk package. The label states use by intramuscular or intravenous route, storage at controlled room temperature, and includes dosage and dilution instructions. Distributed by Medical Purchasing Solutions, Scottsdale, AZ.*

FDA Label Image

Chemical Structure (Cleocin Solution 01)

Chemical structure of clindamycin phosphate, the active ingredient in Cleocin Phosphate injection solution. The diagram shows the molecular arrangement including rings, functional groups, and phosphate moiety relevant to this antibiotic.*

FDA Label Image

Logo (Cleocin Solution 02)

Cleocin Phosphate injection solution, 150 mg/mL, in a vial labeled as Pfizer Injectables. Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, New York, NY 10017. The label mentions the product is a human prescription drug for intramuscular and intravenous use.*

FDA Label Image

Figure 1 And 2 (Cleocin Solution 03)

Instructional diagrams showing how to remove and open a safety cap from a vial. Figure 1 depicts a hand lifting the tamper-evident seal from the vial. Figure 2 shows the cap being twisted off and lifted upward to open the vial.*

FDA Label Image

Figure 3 And 4 (Cleocin Solution 04)

An instructional illustration showing hands demonstrating specific steps to manipulate or open a small vial or container, likely related to preparation or use of the Cleocin Phosphate injection solution.*

FDA Label Image

Figure 5 And 6 (Cleocin Solution 05)

An instructional diagram showing two sequential steps (Fig. 5 and Fig. 6) of manipulating a medical injection bag or container. Each figure depicts a hand interacting with the container, likely demonstrating how to prepare or handle the injection solution.*

FDA Label Image

Logo (Cleocin Solution 05a)

Cleocin Phosphate clindamycin phosphate injection solution 150 mg/mL label highlighting its distribution by Pharmacia & Upjohn Co., a division of Pfizer Inc., with the New York, NY address. The label features the Pfizer Injectables logo.*

FDA Label Image

Principal Display Panel (9,000 mg/60 mL Vial Bulk Label)

Label for Cleocin Phosphate clindamycin injection, USP, 9,000 mg/60 mL (150 mg/mL) solution for injection. The label shows it is a 60 mL pharmacy bulk package for intramuscular or intravenous use, not for direct infusion. Distributed by Pharmacia & Upjohn Co, division of Pfizer Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.